ESC Premium Access

First-in-man study of the dedicated bifurcation cobalt-chromium sirolimus-eluting stent: 9-month interim results.

Congress Presentation

About the speaker

Professor Robert Gil

National Medical Institute of the Ministry of Internal Affairs, Warsaw (Poland)
1 presentation
0 follower

9 more presentations in this session

A meta-analysis of randomised controlled trials to compare safety and efficacy of everolimus/sirolimus bioabsorbable polymer with second-generation durable-polymer drug eluting stents

Speaker: Associate Professor K. Singh (Gold Coast, AU)


Unique stent design with continuous cobalt wire can avoid protruding immediately after percutaneous coronary intervention compared to classical tubed stent.

Speaker: Doctor D. Nakamura (Osaka, JP)


Clinical impact of implanted stent length on clinical outcomes in patients treated with second-generation DES: a pooled analysis from RESET and NEXT trial

Speaker: Mr H. Watanabe (Wakayama, JP)


A five-year follow-up of randomised studies comparing outcomes between bioabsorbable-polymer and durable-polymer drug-eluting stents: systematic review and meta-analysis

Speaker: Associate Professor K. Singh (Gold Coast, AU)


Drug-eluting balloon in the side branch of bifurcation lesions induces late lumen enlargement in the follow-up period

Speaker: Doctor D. Gulin (Jonkoping, SE)


Access the full session

Poster Session 6 - Coronary interventions

Speakers: Professor R. Gil, Associate Professor K. Singh, Doctor D. Nakamura, Mr H. Watanabe, Associate Professor K. Singh...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb